Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 16/20 | 0.74 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.74 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.64 |
| ▸ | FYN | P06241 | 2/20 | 0.40 |
| ▸ | BMPR1A | P36894 | 1/20 | 0.40 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.40 |
| ▸ | ACVRL1 | P37023 | 1/20 | 0.40 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.38 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL932012 | 0.86 | BACE1 (0.78) | BACE1BACE2KCNH2 | |
| SCHEMBL6921764 | 0.85 | BACE1 (1.00) | BACE1BACE2KCNH2 | |
| SCHEMBL931639 | 0.85 | BACE1 (1.00) | BACE1BACE2KCNH2 | |
| SCHEMBL931641 | 0.85 | BACE1 (1.00) | BACE1BACE2KCNH2 | |
| SCHEMBL932576 | 0.84 | BACE1 (0.82) | BACE1BACE2KCNH2 | |
| SCHEMBL932133 | 0.84 | BACE1 (0.78) | BACE1BACE2KCNH2 | |
| SCHEMBL932004 | 0.83 | BACE1 (0.69) | BACE1BACE2KCNH2 | |
| SCHEMBL932107 | 0.83 | BACE1 (0.72) | BACE1BACE2KCNH2FYNHSD17B1 | |
| SCHEMBL1073622 | 0.82 | BACE1 (0.71) | BACE1BACE2KCNH2 | |
| SCHEMBL932170 | 0.81 | BACE1 (0.64) | BACE1BACE2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011002407-A1 | NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA | ASTRAZENECA AB (SE) | 2011-01-06 | — | — | WO | claimed |
| WO-2011002407-A1 | NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA | ASTRAZENECA AB (SE) | 2011-01-06 | — | — | WO | disclosed |